Journal of the American Society of Echocardiography
Volume 22, Issue 11 , Pages 1199-1208 , November 2009

Factors Affecting Sensitivity and Specificity of Diagnostic Testing: Dobutamine Stress Echocardiography

References 

  1. Geleijnse ML, Fioretti PM, Roelandt JR. Methodology, feasibility, safety and diagnostic accuracy of dobutamine stress echocardiography. J Am Coll Cardiol. 1997;30:595–606
  2. Hoffmann R, Lethen H, Marwick T, Arnese M, Fioretti P, Pingitore A, et al. Analysis of interinstitutional observer agreement in interpretation of dobutamine stress echocardiograms. J Am Coll Cardiol. 1996;27:330–336
  3. Hlatky MA, Pryor DB, Harrell FE, Califf RM, Mark DB, Rosati RA. Factors affecting sensitivity and specificity of exercise electrocardiography. Multivariable analysis. Am J Med. 1984;77:64–71
  4. Detrano R, Janosi A, Lyons KP, Marcondes G, Abbassi N, Froelicher VF. Factors affecting sensitivity and specificity of a diagnostic test: the exercise thallium scintigram. Am J Med. 1988;84:699–710
  5. Afridi I, Quinones MA, Zoghbi WA, Cheirif J. Dobutamine stress echocardiography: sensitivity, specificity, and predictive value for future cardiac events. Am Heart J. 1994;127:1510–1515
  6. Ahmad M, Xie T, McCulloch M, Abreo G, Runge M. Real-time three-dimensional dobutamine stress echocardiography in assessment stress echocardiography in assessment of ischemia: comparison with two-dimensional dobutamine stress echocardiography. J Am Coll Cardiol. 2001;37:1303–1309
  7. Anthopoulos LP, Bonou MS, Kardaras FG, Sioras EP, Kardara DN, Sideris AM, et al. Stress echocardiography in elderly patients with coronary artery disease: applicability, safety and prognostic value of dobutamine and adenosine echocardiography in elderly patients. J Am Coll Cardiol. 1996;28:52–59
  8. Beleslin BD, Ostojic M, Stepanovic J, Djordjevic-Dikic A, Stojkovic S, Nedeljkovic M, et al. Stress echocardiography in the detection of myocardial ischemia. Head- to-head comparison of exercise, dobutamine, and dipyridamole tests. Circulation. 1994;90:1168–1176
  9. Cain P, Baglin T, Case C, Spicer D, Short L, Marwick TH. Application of tissue Doppler to interpretation of dobutamine echocardiography and comparison with quantitative coronary angiography. Am J Cardiol. 2001;87:525–531
  10. Carstensen S, Host U, Saunamaki K, Kelbaek H. Quantitative analysis of dobutamine-atropine stress echocardiography by fractional area change. Eur J Echocardiogr. 2002;3:220–228
  11. Chiou KR, Huang WC, Lin SL, Hsieh PL, Liu CP, Tsay DG, et al. Real-time dobutamine stress myocardial contrast echocardiography for detecting coronary artery disease: correlating abnormal wall motion and disturbed perfusion. Can J Cardiol. 2004;20:1237–1243
  12. Cohen JL, Greene TO, Ottenweller J, Binenbaum SZ, Wilchfort SD, Kim CS. Dobutamine digital echocardiography for detecting coronary artery disease. Am J Cardiol. 1991;67:1311–1318
  13. Dagianti A, Penco M, Agati L, Sciomer S, Rosanio S, Fedele F. Stress echocardiography: comparison of exercise, dipyridamole and dobutamine in detecting and predicting the extent of coronary artery disease. J Am Coll Cardiol. 1995;26:18–25
  14. Daoud EG, Pitt A, Armstrong WF. Electrocardiographic response during dobutamine stress echocardiography. Am Heart J. 1995;129:672–677
  15. Di Bello V, Bellina CR, Gori E, Molea N, Talarico L, Boni G, et al. Incremental diagnostic value of dobutamine stress echocardiography and dobutamine scintigraphy (technetium 99m-labeled sestamibi single-photon emission computed tomography) for assessment of presence and extent of coronary artery disease. J Nucl Cardiol. 1996;3:212–220
  16. Dionisopoulos PN, Collins JD, Smart SC, Knickelbine TA, Sagar KB. The value of dobutamine stress echocardiography for the detection of coronary artery disease in women. J Am Soc Echocardiogr. 1997;10:811–817
  17. Elhendy A, van Domburg RT, Poldermans D, Bax JJ, Nierop PR, Geleijnse ML, et al. Safety and feasibility of dobutamine-atropine stress echocardiography for the diagnosis of coronary artery disease in diabetic patients unable to perform an exercise stress test. Diabetes Care. 1998;21:1797–1802
  18. Elhendy A, O'Leary EL, Xie F, McGrain AC, Anderson JR, Porter TR. Comparative accuracy of real-time myocardial contrast perfusion imaging and wall motion analysis during dobutamine stress echocardiography for the diagnosis of coronary artery disease. J Am Coll Cardiol. 2004;44:2185–2191
  19. Epstein M, Gin K, Sterns L, Pollick C. Dobutamine stress echocardiography: initial experience of a Canadian centre. Can J Cardiol. 1992;8:273–279
  20. Eroglu E, D'Hooge J, Herbots L, Thijs D, Dubois C, Sinnaeve P, et al. Comparison of real-time tri-plane and conventional 2D dobutamine stress echocardiography for the assessment of coronary artery disease. Eur Heart J. 2006;27:1719–1724
  21. Fathi R, Cain P, Nakatani S, Yu HC, Marwick TH. Effect of tissue Doppler on the accuracy of novice and expert interpreters of dobutamine echocardiography. Am J Cardiol. 2001;88:400–405
  22. Gunalp B, Dokumaci B, Uyan C, Vardareli E, Isik E, Bayhan H, et al. Value of dobutamine technetium-99m-sestamibi SPECT and echocardiography in the detection of coronary artery disease compared with coronary angiography. J Nucl Med. 1993;34:889–894
  23. Hennessy TG, Codd MB, Kane G, McCarthy C, McCann HA, Sugrue DD. Dobutamine stress echocardiography in the detection of coronary artery disease: importance of the pretest likelihood of disease. Am Heart J. 1997;134:685–692
  24. Ho FM, Huang PJ, Liau CS, Lee FK, Chieng PU, Su CT, et al. Dobutamine stress echocardiography compared with dipyridamole thallium- 201 single-photon emission computed tomography in detecting coronary artery disease. Eur Heart J. 1995;16:570–575
  25. Ho YL, Wu CC, Lin LC, Liu YB, Chen WJ, Chen MF, et al. Assessment of the functional significance of coronary artery stenosis by dobutamine-atropine stress echocardiography. Cardiology. 1997;88:386–392
  26. Hoffmann R, Lethen H, Kleinhans E, Weiss M, Flachskampf FA, Hanrath P. Comparative evaluation of bicycle and dobutamine stress echocardiography with perfusion scintigraphy and bicycle electrocardiogram for identification of coronary artery disease. Am J Cardiol. 1993;72:555–559
  27. Huang PJ, Ho YL, Wu CC, Chao CL, Chen MF, Chieng PU, et al. Simultaneous dobutamine stress echocardiography and thallium-201 perfusion imaging for the detection of coronary artery disease. Cardiology. 1997;88:556–562
  28. Iwase M, Fukui M, Tamagaki H, Kimura M, Hasegawa K, Matsuyama H, et al. Advantages and disadvantages of dobutamine stress echocardiography compared with treadmill exercise electrocardiography in detecting ischemia. Jpn Circ J. 1996;60:954–960
  29. Kisacik HL, Ozdemir K, Altinyay E, Oguzhan A, Kural T, Kir M, et al. Comparison of exercise stress testing with simultaneous dobutamine stress echocardiography and technetium-99m isonitrile single-photon emission computerized tomography for diagnosis of coronary artery disease. Eur Heart J. 1996;17:113–119
  30. Lewis JF, Lin L, McGorray S, Pepine CJ, Doyle M, Edmundowicz D, et al. Dobutamine stress echocardiography in women with chest pain. Pilot phase data from the National Heart, Lung and Blood Institute Women's Ischemia Syndrome Evaluation (WISE). J Am Coll Cardiol. 1999;33:1462–1468
  31. Ling LH, Pellikka PA, Mahoney DW, Oh JK, McCully RB, Roger VL, et al. Atropine augmentation in dobutamine stress echocardiography: role and incremental value in a clinical practice setting. J Am Coll Cardiol. 1996;28:551–557
  32. Loimaala A, Groundstroem K, Pasanen M, Oja P, Vuori I. Comparison of bicycle, heavy isometric, dipyridamole-atropine and dobutamine stress echocardiography for diagnosis of myocardial ischemia. Am J Cardiol. 1999;84:1396–1400
  33. Marcovitz PA, Armstrong WF. Accuracy of dobutamine stress echocardiography in detecting coronary artery disease. Am J Cardiol. 1992;69:1269–1273
  34. Martin TW, Seaworth JF, Johns JP, Pupa LE, Condos WR. Comparison of adenosine, dipyridamole, and dobutamine in stress echocardiography. Ann Intern Med. 1992;116:190–196
  35. Marwick T, D'Hondt AM, Baudhuin T, Willemart B, Wijns W, Detry JM, et al. Optimal use of dobutamine stress for the detection and evaluation of coronary artery disease: combination with echocardiography or scintigraphy, or both?. J Am Coll Cardiol. 1993;22:159–167
  36. Mathias W, Tsutsui JM, Andrade JL, Kowatsch I, Lemos PA, Leal SM, et al. Value of rapid beta-blocker injection at peak dobutamine-atropine stress echocardiography for detection of coronary artery disease. J Am Coll Cardiol. 2003;41:1583–1589
  37. Mazeika PK, Nadazdin A, Oakley CM. Dobutamine stress echocardiography for detection and assessment of coronary artery disease. J Am Coll Cardiol. 1992;19:1203–1211
  38. McNeill AJ, Fioretti PM, el-Said SM, Salustri A, Forster T, Roelandt JR. Enhanced sensitivity for detection of coronary artery disease by addition of atropine to dobutamine stress echocardiography. Am J Cardiol. 1992;70:41–46
  39. Mishra MB, Lythall DA, Chambers JB. A comparison of wall motion analysis and systolic left ventricular long axis function during dobutamine stress echocardiography. Eur Heart J. 2002;23:579–585
  40. Nagel E, Lehmkuhl HB, Bocksch W, Klein C, Vogel U, Frantz E, et al. Noninvasive diagnosis of ischemia-induced wall motion abnormalities with the use of high-dose dobutamine stress MRI: comparison with dobutamine stress echocardiography. Circulation. 1999;99:763–770
  41. Nedeljkovic I, Ostojic M, Beleslin B, Djordjevic-Dikic A, Stepanovic J, Nedeljkovic M, et al. Comparison of exercise, dobutamine-atropine and dipyridamole-atropine stress echocardiography in detecting coronary artery disease. Cardiovasc Ultrasound. 2006;4:22
  42. Nixdorff U, Matschke C, Winklmaier M, Flachskampf FA, Ludwig J, Pohle K, et al. Native tissue second harmonic imaging improves endocardial and epicardial border definition in dobutamine stress echocardiography. Eur J Echocardiogr. 2001;2:52–61
  43. Peteiro J, Monserrat L, Fabregas R, Manuel Vazquez J, Calvino R, Castro-Beiras A. Comparison of two-dimensional echocardiography and pulsed Doppler tissue imaging during dobutamine-atropine stress testing to detect coronary artery disease. Echocardiography. 2001;18:275–284
  44. Pingitore A, Picano E, Colosso MQ, Reisenhofer B, Gigli G, Lucarini AR, et al. Echo Persantine (EPIC) and Echo Dobutamine International Cooperative (EDIC) Study Groups. The atropine factor in pharmacologic stress echocardiography. J Am Coll Cardiol. 1996;27:1164–1170
  45. Previtali M, Lanzarini L, Fetiveau R, Poli A, Ferrario M, Falcone C, et al. Comparison of dobutamine stress echocardiography, dipyridamole stress echocardiography and exercise stress testing for diagnosis of coronary artery disease. Am J Cardiol. 1993;72:865–870
  46. Rollan MJ, San Roman JA, Vilacosta I, Ortega JR, Serrador A, Pastor G, et al. The influence of sex on the performance of dobutamine echocardiography for the diagnosis of ischemic cardiopathy. Rev Esp Cardiol. 1999;52:1060–1065
  47. Sahin M, Karakelleoglu S, Alp N, Atesal S, Senocak H. Diagnostic value of dobutamine stress echocardiography in coronary artery disease. Thorac Cardiovasc Surg. 1994;42:285–289
  48. Salustri A, Fioretti PM, Pozzoli MM, McNeill AJ, Roelandt JR. Dobutamine stress echocardiography: its role in the diagnosis of coronary artery disease. Eur Heart J. 1992;13:70–77
  49. San Roman JA, Vilacosta I, Castillo JA, Rollan MJ, Peral V, Sanchez-Harguindey L, et al. Dipyridamole and dobutamine-atropine stress echocardiography in the diagnosis of coronary artery disease. Comparison with exercise stress test, analysis of agreement, and impact of antianginal treatment. Chest. 1996;110:1248–1254
  50. Santiago P, Vacek JL, Rosamond TL. Dobutamine stress echocardiography: clinical utility and predictive value at various infusion rates. Am Heart J. 1994;128:804–808
  51. Santoro GM, Sciagra R, Buonamici P, Consoli N, Mazzoni V, Zerauschek F, et al. Head-to-head comparison of exercise stress testing, pharmacologic stress echocardiography, and perfusion tomography as first-line examination for chest pain in patients without history of coronary artery disease. J Nucl Cardiol. 1998;5:19–27
  52. Sawada SG, Segar DS, Ryan T, Brown SE, Dohan AM, Williams R, et al. Echocardiographic detection of coronary artery disease during dobutamine infusion. Circulation. 1991;83:1605–1614
  53. Schroder K, Agrawal R, Voller H, Kursten B, Dissmann R, Schultheiss HP. Factors influencing the diagnostic accuracy of dobutamine stress echocardiography. Int J Card Imaging. 1997;13:493–498
  54. Senior R, Sridhara BS, Anagnostou E, Handler C, Raftery EB, Lahiri A. Synergistic value of simultaneous stress dobutamine sestamibi single- photon-emission computerized tomography and echocardiography in the detection of coronary artery disease. Am Heart J. 1994;128:713–718
  55. Slavich GA, Guerra UP, Morocutti G, Fioretti PM, Fresco C, Orlandi C, et al. Feasibility of simultaneous Tc99m sestamibi and 2D-echo cardiac imaging during dobutamine pharmacologic stress. Preliminary results in a female population. Int J Card Imaging. 1996;12:113–118
  56. Smart SC, Bhatia A, Hellman R, Stoiber T, Krasnow A, Collier BD, et al. Dobutamine-atropine stress echocardiography and dipyridamole sestamibi scintigraphy for the detection of coronary artery disease: limitations and concordance. J Am Coll Cardiol. 2000;36:1265–1273
  57. Sochowski RA, Yvorchuk KJ, Yang Y, Rattes MF, Chan KL. Dobutamine and dipyridamole stress echocardiography in patients with a low incidence of severe coronary artery disease. J Am Soc Echocardiogr. 1995;8:482–487
  58. Sozzi FB, Poldermans D, Bax JJ, Boersma E, Vletter WB, Elhendy A, et al. Second harmonic imaging improves sensitivity of dobutamine stress echocardiography for the diagnosis of coronary artery disease. Am Heart J. 2001;142:153–159
  59. Steinberg EH, Madmon L, Patel CP, Sedlis SP, Kronzon I, Cohen JL. Long-term prognostic significance of dobutamine echocardiography in patients with suspected coronary artery disease: results of a 5-year follow-up study. J Am Coll Cardiol. 1997;29:969–973
  60. Takeuchi M, Miura Y, Sonoda S, Kuroiwa A. Comparison of three different protocols for dobutamine stress echocardiography: does the addition of atropine increase complications, and does it improve diagnostic accuracy?. Echocardiography. 1999;16:347–355
  61. Vitarelli A, Luzzi MF, Penco M, Fedele F, Dagianti A. On-line quantitative assessment of left ventricular filling during dobutamine stress echocardiography: a useful addition to conventional wall motion scoring. Int J Cardiol. 1997;59:57–69
  62. Wu CC, Ho YL, Kao SL, Chen WJ, Lee CM, Chen MF, et al. Dobutamine stress echocardiography for detecting coronary artery disease. Cardiology. 1996;87:244–249
  63. Xie F, Tsutsui JM, McGrain AC, Demaria A, Cotter B, Becher H, et al. Comparison of dobutamine stress echocardiography with and without real-time perfusion imaging for detection of coronary artery disease. Am J Cardiol. 2005;96:506–511
  64. Yuda S, Khoury V, Marwick TH. Influence of wall stress and left ventricular geometry on the accuracy of dobutamine stress echocardiography. J Am Coll Cardiol. 2002;40:1311–1319
  65. Salustri A, Fioretti PM, McNeill AJ, Pozzoli MM, Roelandt JR. Pharmacological stress echocardiography in the diagnosis of coronary artery disease and myocardial ischaemia: a comparison between dobutamine and dipyridamole. Eur Heart J. 1992;13:1356–1362
  66. Arnese M, Salustri A, Fioretti PM, Cornel JH, Boersma E, Reijs AE, et al. Quantitative angiographic measurements of isolated left anterior descending coronary artery stenosis. Correlation with exercise echocardiography and technetium-99m 2-methoxy isobutyl isonitrile single-photon emission computed tomography. J Am Coll Cardiol. 1995;25:1486–1491
  67. Baptista J, Arnese M, Roelandt JR, Fioretti P, Keane D, Escaned J, et al. Quantitative coronary angiography in the estimation of the functional significance of coronary stenosis: correlations with dobutamine- atropine stress test. J Am Coll Cardiol. 1994;23:1434–1439
  68. Beleslin BD, Ostojic M, Djordjevic-Dikic A, Babic R, Nedeljkovic M, Stankovic G, et al. Integrated evaluation of relation between coronary lesion features and stress echocardiography results: the importance of coronary lesion morphology. J Am Coll Cardiol. 1999;33:717–726
  69. Heyman J, Salvade P, Picano E, Varga A, Gliozheni E, Sicari R, et al. EDIC (Echo Dobutamine International Cooperative) Study Group. The elusive link between coronary lesion morphology and dobutamine stress echocardiography results. Int J Card Imaging. 1997;13:395–401
  70. Elhendy A, Cornel JH, Roelandt JR, Nierop PR, van Domburg RT, Geleijnse ML, et al. Impact of severity of coronary artery stenosis and the collateral circulation on the functional outcome of dyssynergic myocardium after revascularization in patients with healed myocardial infarction and chronic left ventricular dysfunction. Am J Cardiol. 1997;79:883–888
  71. Weissman NJ, Levangie MW, Guerrero JL, Weyman AE, Picard MH. Effect of beta-blockade on dobutamine stress echocardiography. Am Heart J. 1996;131:698–703
  72. Fioretti PM, Poldermans D, Salustri A, Forster T, Bellotti P, Boersma E, et al. Atropine increases the accuracy of dobutamine stress echocardiography in patients taking beta-blockers. Eur Heart J. 1994;15:355–360
  73. Geleijnse ML, Krenning BJ, Soliman OI, Nemes A, Galema TW, ten Cate FJ. Dobutamine stress echocardiography for the detection of coronary artery disease in women. Am J Cardiol. 2007;99:714–717
  74. Senior R, Lahiri A. Enhanced detection of myocardial ischemia by stress dobutamine echocardiography utilizing the “biphasic” response of wall thickening during low and high dose dobutamine infusion. J Am Coll Cardiol. 1995;26:26–32
  75. Elhendy A, Cornel JH, Roelandt JR, van Domburg RT, Nierop PR, Geleynse ML, et al. Relation between contractile response of akinetic segments during dobutamine stress echocardiography and myocardial ischemia assessed by simultaneous thallium-201 single-photon emission computed tomography. Am J Cardiol. 1996;77:955–959
  76. Elhendy A, van Domburg RT, Bax JJ, Poldermans D, Nierop PR, Kasprzak JD, et al. Optimal criteria for the diagnosis of coronary artery disease by dobutamine stress echocardiography. Am J Cardiol. 1998;82:1339–1344
  77. Rozanski A, Diamond GA, Berman D, Forrester JS, Morris D, Swan HJ. The declining specificity of exercise radionuclide ventriculography. N Engl J Med. 1983;309:518–522
  78. Roger VL, Pellikka PA, Bell MR, Chow CW, Bailey KR, Seward JB. Sex and test verification bias. Impact on the diagnostic value of exercise echocardiography. Circulation. 1997;21(95):405–410
  79. Krenning BJ, Geleijnse ML, Poldermans D, Roelandt JR. Methodological analysis of diagnostic dobutamine stress echocardiography studies. Echocardiography. 2004;21:725–736
  80. Philbrick JT, Horwitz RI, Feinstein AR, Langou RA, Chandler JP. The limited spectrum of patients studied in exercise test research. Analyzing the tip of the iceberg. JAMA. 1982;248:2467–2470
  81. Wasson JH, Sox HC, Neff RK, Goldman L. Clinical prediction rules. Applications and methodological standards. N Engl J Med. 1985;313:793–799
  82. Diamond GA. Monkey business. Am J Cardiol. 1986;57:471–475

PII: S0894-7317(09)00630-0

doi: 10.1016/j.echo.2009.07.006

Journal of the American Society of Echocardiography
Volume 22, Issue 11 , Pages 1199-1208 , November 2009

Article Tools